Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation. We report on innovative drug introductions and promising pipeline candidates from Big Pharma and smaller players, as well as relevant clinical trial trends. WIth the growing interest in artificial intelligence and machine learning in drug discovery and development, we provide insights into the latest AI-driven methodologies, platforms, and tools being harnessed by the industry, showcasing real-world applications and case studies that highlight the tangible benefits and challenges of integrating these technologies.
The publication also covers promising technological developments relevant to the biotech, biopharma and pharma industries, including advances in artificial intelligence, genomic/proteomic sequencing and microscopy. Other areas of focus include orphan drugs, drug advances for oncology, neurological disease and infectious disease including vaccines and other therapies for infectious disease.
In the AI domain, our aim is to create a nexus where pharma professionals, data scientists, AI experts, and other stakeholders can gain a holistic understanding of the evolving drug discovery landscape, enriched by the capabilities of artificial intelligence and machine learning.
Our content includes staff-written articles as well as contributed content from experts.
The publication serves the pharmaceutical, biopharmaceutical and biotechnology industries, contract research organizations, government laboratories, universities, hospitals, medical centers and others within the life science marketplace.
Our readers include informatics specialists, staff scientists, research scientists, corporate and lab management and scientists conducting and leading research within the field.
Sign up for our free e-newsletter to stay up to date with the top current stories of the drug discovery and development industry.
Drug Discovery and Development is a pharmaceutical industry news website, owned by Cleveland-based Arrowfly. We stand by journalistic ethics to provide the most up-to-date, accurate and fairly reported information for our readers.
Meet the Team
Brian Buntz
Pharma Editor
Brian is an experienced journalist with more than fifteen years’ experience covering an array of technologies including medical devices, artificial intelligence and cybersecurity. He has held a variety of senior editorial roles over the past decade at Penton and UBM (both now Informa). Multilingual, Brian has an M.A. degree in German from the University of Oklahoma.
Julia Rock-Torcivia
Associate Editor
Julia graduated from Lehigh University in 2025 with a Bachelor’s Degree in English and minors in Mass Communications and Biology. She worked as a news reporter on Lehigh’s newspaper, The Brown and White. During the summer of 2024, Julia received a fellowship to study abroad at the University of Galway and worked as a research assistant for STEMMA, a project using AI to investigate routes of early modern poetry.
Chris Newmarker
Executive Editor, Life Sciences
A professional journalist of 18 years, Chris Newmarker is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He presently manages Arrowfly life science news websites and publications including MassDevice, Medical Design & Outsourcing and more. Mr. Newmarker holds bachelor’s degrees in journalism and political science from Ohio State University.
Amy Vodraska
Regional Sales Manager
Amy Vodraska is an accomplished Sales Director and Publisher with extensive experience driving business development and client success in B2B media. She specializes in creating integrated marketing strategies, including digital, content, and events, especially for the life science and healthcare markets.
Brian Toole
Regional Sales Manager
Brian Toole has 30 years of experience in business-to-business marketing. Prior to joining Arrowfly, he worked at Cahners, Reed, UBM and Informa. He earned his bachelor’s degree from the University of Delaware. Before leaving this world, he would truly like to see the Philadelphia Flyers win the Stanley Cup one more time (1974 was the last one).
For subscription services, sales inquiries, questions or to submit a news release, please visit the contact page for our parent company, Arrowfly.